GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Margin of Safety % (DCF Earnings Based)

Divi's Laboratories (NSE:DIVISLAB) Margin of Safety % (DCF Earnings Based) : -494.07% (As of Jun. 13, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2025-06-13), Divi's Laboratories's Predictability Rank is 4-Stars. Divi's Laboratories's intrinsic value calculated from the Discounted Earnings model is ₹1132.02 and current share price is ₹6725.00. Consequently,

Divi's Laboratories's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is -494.07%.

Competitive Comparison of Divi's Laboratories's Margin of Safety % (DCF Earnings Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Divi's Laboratories's Margin of Safety % (DCF Earnings Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's Margin of Safety % (DCF Earnings Based) falls into.


;
;

Divi's Laboratories Margin of Safety % (DCF Earnings Based) Calculation

Divi's Laboratories's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(1132.02-6725.00)/1132.02
=-494.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

Divi's Laboratories Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Margin of Safety % (DCF Earnings Based)
Comparable Companies
BOM:500087 NSE:TORNTPHARM BOM:500124 BOM:543904 BOM:532321 BOM:500257 NSE:AUROPHARMA BOM:500488 NSE:ALKEM BOM:543064 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ HKSE:03692 XTAE:TEVA SHSE:688506
Traded in Other Exchanges
532488:India
Address
Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Website
https://www.divislabs.com
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines